abstract |
A method and composition are disclosed for administering pyruvate in high doses to mammals, including humans. The method and composition do not produce an excessive acid load, salt load, or nitrogen load. Bioavailability of pyruvate from the composition is high. The composition has been named 'tripyruvin' (tripyruvyl glycerol, or glycerol tripyruvate), and has structure (I). |